A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/485 (2006.01) A61K 9/00 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 9/24 (2006.01) A61K 9/26 (2006.01) A61K 9/30 (2006.01) A61K 9/32 (2006.01) A61K 9/36 (2006.01) A61P 25/04 (2006.01)
Patent
CA 2474904
The invention is directed to sustained release formulations containing oxycodone or a pharmaceutically acceptable salt thereof which provide a mean C24/Cmax oxycodoen ratio of 0.6 to 1.0 or 0.7 to 1 after oral administration at steady state to patients and methods thereof.
La présente invention concerne des formulations à libération prolongée, qui contiennent de l'oxycodone ou un sel de celle-ci, acceptable d'un point de vue pharmaceutique, et qui fournissent un rapport d'oxycodone C¿24?/C¿max? moyen allant de 0,6 à 1,0 ou de 0,7 à 1, après une administration par voie orale à des patients à l'état stationnaire. La présente invention concerne également des procédés pour mettre en oeuvre ces formulations.
Oshlack Benjamin
Prater Derek
Wright Curtis
Borden Ladner Gervais Llp
Euro-Celtique S.a.
LandOfFree
Once-a-day oxycodone formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Once-a-day oxycodone formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Once-a-day oxycodone formulations will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1342358